Follow the Wuhan YZY Biopharma Co., Ltd. - B - H Shares stock price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares are quoted on the HK market, under the authority of HKEX. The latest transaction was reported on 16 June 2026 (Other). Among the most active insiders: ZHOU HONGFENG. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Wuhan YZY Biopharma Co., Ltd. is a biopharmaceutical company that provides innovative solutions for the treatment of various diseases. It is listed under the B category of H shares.